• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Rentrak Announces Official Worldwide Box Office Results for Weekend of June 28, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of June 28, 2015

  2. Rentrak Announces Official Worldwide Box Office Results for Weekend of June 21, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of June 21, 2015

  3. Rentrak Announces Official Worldwide Box Office Results for Weekend of June 14, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of June 14, 2015

  4. Rentrak Announces Official Worldwide Box Office Results for Weekend of June 7, 2015

    Rentrak Announces Official Worldwide Box Office Results for Weekend of June 7, 2015

  5. Sanofi's Lyxumia® (lixisenatide) Statistically Superior to Rapid Acting Insulin for Body Weight Change with Similar Blood Sugar Control when Both are Added to Basal Insulin

    Sanofi's Lyxumia® (lixisenatide) Statistically Superior to Rapid Acting Insulin for Body Weight Change with Similar Blood Sugar Control when Both are Added to Basal Insulin

  6. FDA Grants Breakthrough Therapy Designation for Genzyme’s Olipudase Alfa

    FDA Grants Breakthrough Therapy Designation for Genzyme’s Olipudase Alfa

  7. UPDATE: European stocks jittery on hopes of Greek debt deal

    UPDATE: European stocks jittery on hopes of Greek debt deal

  8. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  9. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  10. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

    Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.